Plant-Based Compositions And Methods For Modulation of Inflammatory Response Post Viral Infection
AssigneeVDF Futureceuticals, Inc.
InventorsBoris Nemzer, Pietrzkowski Zbigniew, John M Hunter
Life of this patent
Estimating the term…
Loading patent…
AssigneeVDF Futureceuticals, Inc.
InventorsBoris Nemzer, Pietrzkowski Zbigniew, John M Hunter
Estimating the term…
A polyphenol-rich composition is orally administered to alleviate a sign or symptom of a post-viral syndrome, and preferably post-COVID syndrome. Most typically, the composition comprises at least 50 wt % total catechins, at least 20 wt % total chlorogenic acids, and optionally up to 30 wt % total supplemental antioxidants. The composition may be formulated from a green coffee bean extract, a green tea extract, a turmeric extract, a tart cherry or extract thereof, a broccoli or extract thereof, and a kale or extract thereof. Notably, such compositions were effective in individuals post SARS-CoV2 infection to reduce proinflammatory cytokines and interleukins, increase NOHb, and to reduce reactive oxygen species due to mitochondrial dysfunction, iNOS activity, and NOX2 activity.
A method of alleviating a sign or symptom of a post-viral syndrome, comprising:
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A polyphenol-rich composition for treatment of a sign or symptom of a post-viral syndrome, wherein the composition predominantly comprises a plurality of chemically distinct catechins and plurality of chemically distinct chlorogenic acids, and wherein the composition, upon oral administration at a dosage of between 10-150 mg, acutely modifies multiple and distinct pathways that generate reactive oxygen species, thereby alleviating the sign or symptom of the post-viral syndrome, optionally wherein alleviating the sign or symptom of post-viral syndrome occurs within 30 minutes and 3 hours upon administration.
24-28. (canceled)
34-57. (canceled)
Dependencies are inferred from the claim text.